logo
  • About
  • Plus Three
  • Power Trip
  • Store
  • Donate
  • Search

Rachael Petersen

Rachael is a writer and environmental consultant who advises nonprofits and foundations on climate change. With an expertise in tropical forests, Rachael has conducted fieldwork in the Brazilian and Ecuadorian Amazon, Borneo, Uganda and elsewhere. After almost a decade in climate policy, Rachael has turned her attention to the spiritual implications of our current ecological crises. Rachael stumbled into psychedelics as a participant in a psilocybin clinical trial for major depression. Her writing excavates the potential risks, rewards, and societal implications of medicalizing and commercializing mysticism. Her work interrogates the intersection of the mystical and the moral, and envisions the role of non-ordinary states of consciousness in current and future forms of religion. Rachael explores these themes as a Junior Fellow at Harvard University's Center for the Study of World Religions.


[molongui_author_posts count=100 list_divider=”yes” show_date=”yes”]

Your Brain on Psychedelic Drugs

November 2, 2017

What is it about psychedelics that has the power to change lives for the better? The answer might lie in the unique ways that psychedelics interact with the brain.


Whitewashing Psychedelics: A Lack of Diverse Voices in the Psychedelic Movement

November 7, 2017

Nick Powers stands alone on stage as the only black speaker and the last voice to close out a conference on psychedelics.


Maine Gov vetoes (admittedly flawed) legal cannabis bill, leaving future sales uncertain

November 9, 2017

On Friday, November 3, 2017, Maine Governor Paul LePage (R) vetoed legislation to regulate cannabis sales in the state.


The State: The Opioid Epidemic

November 14, 2017

For anyone who remembers the Reagan Administration's awesome response to the '80s crack epidemic, the Trump plan may prompt discouraging deja vu.


Cocaine Tourism in Colombia

November 15, 2017

Medellín attracts the attention of tourists seeking a new kind of experience: doing cocaine in the city of Pablo Escobar.


Could Oregon be the First State to Legalize Psilocybin Therapy?

November 20, 2017

A group in Oregon is drafting a ballot initiative for 2020 that would allow individuals to take psilocybin in supervised settings.


Johns Hopkins studying effects of psilocybin on brains of long-term meditators

November 22, 2017

Are these states really similar? Many meditators have answered quite clearly, yes.


Applying to Law School on LSD

November 27, 2017

My decision to attend law school was unconventional, at best.


Ibogaine presents unique challenges in how we approach harm reduction and treat addiction | Part 1

December 4, 2017

The Ibogaine Conversation Part 1 | This series explores the unique challenges ibogaine presents in how we approach plant medicine, harm reduction, and treatment for addiction, through the lens of ibogaine researchers, providers, patients, and advocates from around the world.


Taking Iboga with the People of Gabon | Part 2

December 4, 2017

The Ibogaine Conversation Part 2 | Our first stop is in Gabon, Africa, where consumption of the iboga root bark is intimately tied to the ancient spiritual discipline known as Bwiti.


Loading…

Join Our Newsletter

Independent reporting. Critical analysis. In your inbox.

Text

About
Donate

Store
Power Trip
Plus Three Podcast

Text

Media Requests
Send Us A Tip
Editorial Policy
Subscribe
Archive

Image

Text

Text

About
Donate

Store
Power Trip
Plus Three Podcast

Text

Media Requests
Send Us A Tip
Editorial Policy
Subscribe
Archive

Image

Psymposia is a 501(c)(3) non-profit media organization that offers critical perspectives on drugs, politics, and culture. We reject corporate advertising and rely on contributions from our readers and listeners. Click here to donate today.

Privacy. Terms of Use. © Psymposia, Inc. All Rights Reserved

Image

Text

About
Donate
Store
Power Trip
Podcast

Media Requests
Send Us A Tip

Editorial Policy
Subscribe
Archive

Privacy
Terms of Use

Psymposia is a 501(c)(3) non-profit media organization that offers leftist perspectives on drugs, politics, and culture. We reject corporate advertising and rely on contributions from our readers and listeners. Click here to donate today.

© Psymposia, Inc. All Rights Reserved

Image

Image

Text

About
Donate
Store
Power Trip
Podcast

Media Requests
Send Us A Tip

Editorial Policy
Subscribe
Archive

Privacy
Terms of Use

Psymposia is a 501(c)(3) non-profit media organization that offers leftist perspectives on drugs, politics, and culture. We reject corporate advertising and rely on contributions from our readers and listeners. Click here to donate today.

© Psymposia, Inc. All Rights Reserved

Image

  • About
  • Power Trip
  • Plus Three
  • Store
  • Support us on Patreon
  • Donate
  • Psychedelics
  • Corporadelic
  • Culture
  • Ethics
  • Series
  • Editorial Policies
  • Subscribe
  • Submissions
  • Send Us a Tip
  • Media Requests
  • Archive

Psymposia is a 501(c)(3) research non-profit with a mission to educate the public on psychedelic science and harm reduction.

Privacy Terms of Use

shiftnav-1

  • About
  • Plus Three
  • Power Trip
  • Store
  • Donate